Published June 2021
| Version v1.0.0
Journal Article
Open
A method for detection of SARS-CoV-2 RNA in healthy human stool: a validation study
Creators
- Coryell, Michael P.1
- Iakiviak, Mikhail2
- Pereira, Nicole2
- Murugkar, Pallavi P.2
- Rippe, Jason3
- Williams, David B.3
- Heald-Sargent, Taylor Alis3, 4
- Sanchez-Pinto, Lazaro Nelson3, 4
- Chavez, Jairo3, 4
- Hastie, Jessica L.1
- Sava, Rosa L.1
-
Lien, Christopher Z.1
- Wang, Tony T.1
- Muller, William J3, 4
- Fischbach, Michael A.2
- Carlson, Paul E. Jr.1
Abstract
Background Faecal shedding of SARS-CoV-2 has raised concerns about transmission through faecal microbiota transplantation procedures. Validation parameters of authorised tests for SARS-CoV-2 RNA detection in respiratory samples are described in product labelling, whereas the published methods for SARS-CoV-2 detection from faecal samples have not permitted a robust description of the assay parameters. We aimed to develop and validate a test specifically for detection of SARS-CoV-2 in human stool. Methods In this validation study, we evaluated performance characteristics of a reverse transcriptase real-time PCR (RT-rtPCR) test for detection of SARS-CoV-2 in human stool specimens by spiking stool with inactivated SARS-CoV-2 material. A modified version of the US Centers for Disease Control and Prevention RT-rtPCR SARS-CoV-2 test was used for detection of viral RNA. Analytical sensitivity was evaluated in freshly spiked stool by testing two-fold dilutions in replicates of 20. Masked samples were tested by a second laboratory to evaluate interlaboratory reproducibility. Short-term (7-day) stability of viral RNA in stool samples was assessed with four different stool storage buffers (phosphate-buffered saline, Cary-Blair medium, Stool Transport and Recovery [STAR] buffer, and DNA/RNA Shield) kept at -80 degrees C, 4 degrees C, and ambient temperature (approximately 21 degrees C). We also tested clinical stool and anal swab specimens from patients who were SARS-CoV-2 positive by nasopharyngeal testing. Findings The lower limit of detection of the assay was found to be 3000 viral RNA copies per g of original stool sample, with 100% detection across 20 replicates assessed at this concentration. Analytical sensitivity was diminished by approximately two times after a single freeze-thaw cycle at -80 degrees C. At 100 times the limit of detection, spiked samples were generally stable in all four stool storage buffers tested for up to 7 days, with maximum changes in mean threshold cycle values observed at -80 degrees C storage in Cary-Blair medium (from 29.4 [SD 0.27] at baseline to 30.8 [0.17] at day 7; p<0.0001), at 4 degrees C storage in DNA/RNA Shield (from 28.5 [0.15] to 29.8 [0.09]; p=0.0019), and at ambient temperature in STAR buffer (from 30.4 [0.24] to 32.4 [0.62]; p=0.0083). 30 contrived SARS-CoV-2 samples were tested by a second laboratory and were correctly identified as positive or negative in at least one of two rounds of testing. Additionally, SARS-CoV-2 RNA was detected using this assay in the stool and anal swab specimens of 11 of 23 individuals known to be positive for SARS-CoV-2. Interpretation This is a sensitive and reproducible assay for detection of SARS-CoV-2 RNA in human stool, with potential uses in faecal microbiota transplantation donor screening, sewage monitoring, and further research into the effects of faecal shedding on the epidemiology of the COVID-19 pandemic.Other
number_in_sequence: 8Other
original_citation: Coryell MP, Iakiviak M, Pereira N, Murugkar PP, Rippe J, Williams DB, Heald-Sargent T, Sanchez-Pinto LN, Chavez J, Hastie JL, Sava RL, Lien CZ, Wang TT, Muller WJ, Fischbach MA, Carlson PE. A method for detection of SARS-CoV-2 RNA in healthy human stool: a validation study. Lancet Microbe. 2021;2(6):E259-E266.Files
1-s2.0-S2666524721000598-main.pdf
Files
(520.9 kB)
Name | Size | Download all |
---|---|---|
md5:540f31179df46dc9563f111fb656c360
|
520.9 kB | Preview Download |
Additional details
Identifiers
- PMID
- 33821247
Related works
- Is related to
- https://www.sciencedirect.com/science/article/pii/S2666524721000598?via%3Dihub (URL)
Funding
- Award number AAI1701600100001 AAI1701600100001
- National Institutes of Health
- United States Food and Drug Administration
Dates
- Created
-
2021-06When the item was originally created.